The clinical usefulness of psoriasis vulgaris treatment with an antithyroid drug by the Gunma University method
(in Japanese)
Abe M Ohnishi K Aoyama K Tamura A Ishikawa O Murakami M The clinical usefulness of psoriasis vulgaris treatment with an antithyroid drug by the Gunma University method (in Japanese) Jpn J Dermatol 2000 110 1549 1556
Clinical usefulness of a long-term treatment with an antithyroid drug for psoriasis vulgaris
Hasegawa M Abe M Ohnishi K Shoji C Ishikawa O Clinical usefulness of a long-term treatment with an antithyroid drug for psoriasis vulgaris J Dermatol 2004 10 794 797
Changes in peripheral blood lymphocyte subsets during cyclosporin administration in patients with psoriasis vulgaris
Abe M Ishikawa O Miyachi Y Changes in peripheral blood lymphocyte subsets during cyclosporin administration in patients with psoriasis vulgaris Eur J Dermatol 1997 7 417 420
Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral)
Salek MS Finlay AY Lewis JJ Sumner MI Quality of life improvement in treatment of psoriasis with intermittent short course cyclosporin (Neoral) Qual Life Res 2004 13 91 95
Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study
Ho VC Griffiths CE Berth-Jones J Papp KA Vanaclocha F Dauden E Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study J Am Acad Dermatol 2001 44 643 651
The antipsoriatic effect of thiamazole is not accompanied either by significant changes in blood lymphocyte subsets nor by serum concentration of TNF-α
Abe M Ohnishi K Hasegawa M Aoyama K Tamura A Kan C The antipsoriatic effect of thiamazole is not accompanied either by significant changes in blood lymphocyte subsets nor by serum concentration of TNF-α Eur J Dermatol 2002 12 335 339
Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris
Miyachi Y Ohkawara A Ohkido M et al. Long-term safety and efficacy of high-concentration (20 microg/g) tacalcitol ointment in psoriasis vulgaris Eur J Dermatol 2002 12 463 468
High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids
Katayama I Ohkawara A Ohkido M et al. High-concentration (20 mug/g) tacalcitol ointment therapy on refractory psoriasis vulgaris with low response to topical corticosteroids Eur J Dermatol 2002 12 463 468
Low-dose (1.25 mg/kg) cyclosporin A: Treatment of psoriasis and investigation of the influence on lipid profile
Meffert H Brautigam M Farber L Weidinger G Low-dose (1.25 mg/kg) cyclosporin A: Treatment of psoriasis and investigation of the influence on lipid profile Acta Derm Venereol 1997 77 137 141
Additive effects of calcipotriol and cyclosporine A: From in vitro experiments to in vivo applications in the treatment of severe psoriasis
Bagot M Grossman R Pamphile R et al. Additive effects of calcipotriol and cyclosporine A: From in vitro experiments to in vivo applications in the treatment of severe psoriasis C R Acad Sci 1994 317 282 286
A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study
Grossman RM Thivolet J Claudy A et al. A novel therapeutic approach to psoriasis with combination calcipotriol ointment and very low-dose cyclosporine: Results of a multicenter placebo-controlled study Am Acad Dermatol 1994 31 68 74
Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris
Kokelj F Torsello P Plozzer C Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris J Eur Acad Dermatol Venereol 1998 10 143 146